CERo Therapeutics Holdings - Warrants (13/02/2029) OverviewTrack CERo Therapeutics Holdings - Warrants (13/02/2029)'s operating income ($-18M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026
The latest operating income for CEROW is $-18M as of March 2026. That compares with $-17M in the prior-year period — down 10.6% year over year. Investors often review this figure alongside CERo Therapeutics Holdings - Warrants (13/02/2029)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, CEROW's operating income moved from $-17M to $-18M — a 10.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CERo Therapeutics Holdings - Warrants (13/02/2029)'s operating scale or balance-sheet position.
A operating income figure of $-18M for CEROW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting CEROW's operating income ($-18M), review year-over-year change from $-17M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
